GATA-2 Transduces LPS-Induced il-1β Gene Expression in Macrophages via a Toll-Like Receptor 4/MD88/MAPK-Dependent Mechanism

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wu, Tsu Tuan ^a,b   Tai, Yu Ting ^c   Cherng, Yih Giun ^d   Chen, Tyng Guey ^c   Lin, Chien Ju ^a   Chen, Ta Liang ^e   Chang, Huai Chia ^e   Chen, Ruei Ming ^a,c,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Taipei County Hospital   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR GATA 2;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE INDUCTION; IL 1BETA GENE; MACROPHAGE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ANIMALS; CELLS, CULTURED; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84881162017     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072404     Document Type: Article

References (42)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824. doi:10.1164/ajrccm.149.3.7509706. PubMed: 7509706.
2. Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP, (1999) Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 281: 354-360. doi:10.1001/jama.281.4.354. PubMed: 9929089.
3. Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, et al. (2009) Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 179: 1107-1114. doi:10.1164/rccm.200810-1584OC. PubMed: 19324974.
4. Schingnitz U, Hartmann K, Macmanus CF, Eckle T, Zug S, et al. (2010) Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 184: 5271-5279. doi:10.4049/jimmunol.0903035. PubMed: 20348420.
5. Henneke P, Golenbock DT, (2004) Phagocytosis, innate immunity, and host-pathogen specificity. J Exp Med 199: 1-4. PubMed: 14707110.
6. Calandra T, Roger T, (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800. doi:10.1038/nri1200. PubMed: 14502271.
7. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, et al. (2003) Future research directions in acute lung injury: Summary of a national heart, lung, and blood institute working group. AM Respir Crit Care Med 167: 1027-1035. doi:10.1164/rccm.200208-966WS.
8. Nathan CF, (1987) Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 80: 1550-1560. doi:10.1172/JCI113241. PubMed: 2445780.
9. Ware LB, Matthay MA, (2000) The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349. doi:10.1056/NEJM200005043421806. PubMed: 10793167.
10. Repine JE, (1994) Interleukin-1-mediated acute lung injury and tolerance to oxidative injury. Environ Health Perspect 102: 75-78. doi:10.1289/ehp.94102s1275a. PubMed: 7705311.
11. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801. doi:10.1016/j.cell.2006.02.015. PubMed: 16497588.
12. Beutler B, Rietschel ET, (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169-176. doi:10.1038/nri1004. PubMed: 12563300.
13. Wu GJ, Chen TL, Ueng YF, Chen RM, (2008) Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 228: 105-113. doi:10.1016/j.taap.2007.11.027. PubMed: 18191973.
14. O'Neill LA, Dunne A, Edjeback M, Gray P, Jefferies C, et al. (2003) Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors. J Endotoxin Res 9: 55-59. doi:10.1177/09680519030090010701. PubMed: 12691620.
15. Kolch W, (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6: 827-837. doi:10.1038/nrm1743. PubMed: 16227978.
16. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A, et al. (2004) A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172: 4733-4743. PubMed: 15067049.
17. Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, et al. (2001) Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 69: 1036-1044. PubMed: 11404392.
18. Fan H, Peck OM, Tempel GE, Halushka PV, Cook JA, (2004) Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFκB activation. Shock 22: 57-62. doi:10.1097/01.shk.0000129759.58490.d6. PubMed: 15201703.
19. Sweet MJ, Hume DA, (1996) Endotoxin signal transduction in macrophages. J Leukoc Biol 60: 8-26. PubMed: 8699127.
20. Medzhitov R, Horng T, (2009) Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703. doi:10.1038/nri2634. PubMed: 19859064.
21. Suzuki E, Evans T, Lowry J, Truong L, Bell DW, et al. (1996) The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics 38: 283-290. doi:10.1006/geno.1996.0630. PubMed: 8975704.
22. Burch JB, (2005) Regulation of GATA gene expression during vertebrate development. Semin Cell Dev Biol 16: 71-81. doi:10.1016/j.semcdb.2004.10.002. PubMed: 15659342.
23. Chen RM, Lin YL, Chou CW, (2010) GATA-3 transduces survival signals in osteoblasts through upregulation of bcl-xL gene expression. J Bone Miner Res 25: 2193-2004. doi:10.1002/jbmr.121. PubMed: 20499358.
24. Ho IC, Tai TS, Pai SY, (2009) GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol 9: 125-135. doi:10.1038/nri2476. PubMed: 19151747.
25. Liu W, Zhu ZQ, Wang W, Zu SY, Zhu GJ, (2007) Crucial roles of GATA-2 and SP1 in adrenomedullin-affected expression of tissue factor pathway inhibitor in human umbilical vein endothelial cells exposed to lipopolysaccharide. Thromb Haemost 97: 839-846. PubMed: 17479196.
26. Kitajima K, Tanaka M, Zheng J, Yen H, Sato A, Sugiyama D, et al. (2006) Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2. Blood 107: 1857-1163. doi:10.1182/blood-2005-06-2527. PubMed: 16254139.
27. Wu TT, Chen TL, Chen RM, (2009) Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: validated by RNA interference. Toxicol Lett 191: 195-202. doi:10.1016/j.toxlet.2009.08.025. PubMed: 19735705.
28. Kannan Y, Ushio H, Koyama H, Okada M, Oikawa M, et al. (1991) 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood 77: 1320-1325. PubMed: 1848116.
29. Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W, (1994) Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 174: 5-19. doi:10.1016/0022-1759(94)90005-1. PubMed: 8083537.
30. Chen TL, Chang CC, Lin YL, Ueng YF, et al. (2009) Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1β gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells. Toxicol Appl Pharmacol 240: 15-25. doi:10.1016/j.taap.2009.06.013. PubMed: 19540866.
31. Chiu WT, Lin YL, Chou CW, Chen RM, (2009) Propofol inhibits lipoteichoic acid-induced iNOS gene expression in macrophages possibly through downregulation of toll-like receptor 2-mediated activation of Raf-MEK1/2-ERK1/2-IKK-NFκB. Chembiol Interact 181: 430-439. doi:10.1016/j.cbi.2009.06.011.
32. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, et al. (1998) Databases on Transcriptional Regulation:TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res 26: 364-370.
33. Chang HC, Chen TG, Tai YT, Chen TL, Chiu WT, et al. (2011) Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J Cereb Blood Flow Metab 31: 842-854. doi:10.1038/jcbfm.2010.180. PubMed: 20940732.
34. Chuang CY, Chen TG, Tai YT, Chen TL, Lin YH, et al. (2011) Toll-like receptor 2-mediated sequential activation of MyD88 and MAPKs contributes to lipopolysaccharide-induced sp-a gene expression in human alveolar epithelial cells. Immunobiology 216: 707-714. doi:10.1016/j.imbio.2010.10.009. PubMed: 21112663.
35. Lee CJ, Tai YT, Lin YL, (2010) Molecular mechanisms of propofol-involved suppression of nitric oxide biosynthesis and inducible nitric oxide synthase gene expression in lipopolysaccharide-stimulated macrophage-like Raw 264.7 cells. Shock 33: 93-100. doi:10.1097/SHK.0b013e3181a6eaf5. PubMed: 19333139.
36. Schippers EF, van 't Veer C, van Voorden S, Martina CA, Huizinga TW, et al. (2005) IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 29: 215-228. doi:10.1016/j.cyto.2004.12.005. PubMed: 15760678.
37. Puneet P, McGrath MA, Tay HK, Al-Riyami L, Rzepecka J, Moochhala SM, et al. (2011) The helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88. Nat Immunol 12: 344-351. doi:10.1038/nrm3116. PubMed: 21358639.
38. Dye JR, Palvanov A, Guo B, Rothstein TL, (2007) B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kappa B activation. J Immunol 179: 229-235. PubMed: 17579042.
39. Smith KA, Maizels RM, (2011) Defeating sepsis by misleading MyD88. Nat Immunol 12: 284-286. doi:10.1038/ni0411-284. PubMed: 21423223.
40. Yu YL, Chiang YJ, Chen YC, Papetti M, Juo CG, et al. (2005) MAPK-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival. J Biol Chem 280: 29533-29542. doi:10.1074/jbc.M506514200. PubMed: 15967790.
41. Buck I, Morceau F, Cristofanon S, Heintz C, Chateauvieux S, et al. (2008) Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Biochem Pharmacol 76: 1229-1239. doi:10.1016/j.bcp.2008.08.025. PubMed: 18805401.
42. Bysani GK, Shenep JL, Hildner WK, Stidham GL, Roberson PK, (1990) Detoxification of plasma containing lipopolysaccharide by adsorption. Crit Care Med 18: 67-71. doi:10.1097/00003246-199001000-00015. PubMed: 2403508.